Publications by authors named "J A Singleton"

Article Synopsis
  • A study evaluated HPV vaccination rates among U.S. adolescents born from 1999 to 2009, using data from a national survey between 2016 and 2022.
  • The findings showed significant improvement in vaccination rates before age 13, increasing from 27.0% to 69.8% for those born in 1999 and 2009, respectively, with overall coverage reaching 74.9% by age 17.
  • The analysis identified that preventive healthcare visits and insurance coverage correlate with higher vaccination rates, highlighting that missed opportunities could potentially raise coverage to 94.8%.
View Article and Find Full Text PDF

7 % of pregnant people use opioids. Opioid use during pregnancy can negatively impact maternal and offspring health. Medications for opioid use disorder (MOUD), commonly buprenorphine, are the recommended treatment for opioid use disorder during pregnancy to prevent cycles of withdrawal and relapse.

View Article and Find Full Text PDF

Antiviral therapy is underutilized for outpatients at increased risk for severe COVID-19 or influenza. Results from this survey offer insights into treatment barriers from the infectious disease specialist perspective. Further education is needed about the benefits of early antiviral therapy.

View Article and Find Full Text PDF

Introduction: The Inflation Reduction Act (IRA) eliminated cost sharing for Medicare Part D-covered vaccines but did not address the cost burden faced by Medicare beneficiaries who did not have prescription drug coverage. This study aimed to determine the characteristics of beneficiaries without prescription drug coverage and to assess the association between the receipt of a herpes zoster vaccine and prescription drug coverage status.

Methods: We used the 2019-2023 National Health Interview Survey and included Medicare beneficiaries aged 65 years and older who enrolled in both Parts A and B or a Medicare Advantage plan.

View Article and Find Full Text PDF

The Advisory Committee on Immunization Practices (ACIP) recommends annual influenza and COVID-19 vaccination for all persons aged ≥6 months, including adults aged ≥18 years. ACIP also recommends a single lifetime dose of respiratory syncytial virus (RSV) vaccine for adults aged ≥75 years and for those aged 60-74 years who are at increased risk for severe RSV disease. Data from the National Immunization Survey-Adult COVID Module, a random-digit-dialed cellular telephone survey of U.

View Article and Find Full Text PDF